APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma

Clinical trial NCT04643405 · TERMINATED

Trial details

NCT number: NCT04643405
Sponsor: Ascentage Pharma Group Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Pancreatic Cancer

Start date: 2021-03-17
Primary completion: 2024-06-25
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.